[Use of peroral anti-diabetics in liver lesions].
D003920:Diabetes Mellitus; D005767:Gastrointestinal Diseases; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008107:Liver Diseases / Q000628:therapy*; D009930:Organic Chemicals
D007004:Hypoglycemic Agents; D009930:Organic Chemicals
ANTIDIABETICS/therapeutic use; LIVER DISEASES/therapy
Uber die Anwendung von peroral wirksamen antidiabetischen Mitteln bei Leberschädigungen.